Lars Fruergaard Jørgensen
Lars Fruergaard Jørgensen is the CEO of Novo Nordisk, a leading global healthcare company based in Denmark that specializes in diabetes care and hormone replacement therapies. Under his leadership, the company has focused on innovation and sustainability, driving advancements in diabetes medications and weight management solutions. Recently, he has been vocal about the challenges of high drug prices in the U.S., addressing issues related to pharmacy benefit managers and the pricing mechanisms that affect patient access to medications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Norway | 1 | 3.00 | 0.09% | +0% | 5,421,241 | 5,048 | $403,000 | 375$ |
| United Kingdom | 1 | 4.00 | 0.05% | +0% | 67,886,011 | 32,875 | $2,700,000 | 1,308$ |
| Totals | 2 | 73,307,252 | 37,923 | $3,103,000 | 1,683$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Mike Doustdar was appointed chief executive of Novo Nordisk this summer after his predecessor, Lars Fruergaard Jørgensen, was ousted over concerns the company was losing its dominance in the field.
4
Norway:
Lars Fruergaard Jørgensen was fired as CEO of Novo Nordisk due to declining results.
3
Ireland:
Lars Fruergaard Jørgensen was forced out as chief executive of Novo Nordisk in May after a weak earnings report.
3
United Kingdom:
Lars Fruergaard Jørgensen was replaced as chief executive of Novo Nordisk in May 2025.
5
Denmark:
Lars Fruergaard Jørgensen was the former CEO of Novo Nordisk who predicted layoffs after a tough period for the company.
5
Denmark:
Lars Fruergaard Jørgensen expressed in his farewell that layoffs were on the horizon for Novo Nordisk.
4
Denmark:
Lars Fruergaard Jørgensen, the former CEO of Novo Nordisk, indicated that layoffs were likely.
5
Denmark:
Lars Fruergaard Jørgensen was fired by Lars Rebien Sørensen, leading to significant criticism of the latter.
4
Switzerland:
Lars Fruergaard Jørgensen was the CEO of Novo Nordisk before being separated from the company.
4
United Kingdom:
Lars Fruergaard Jørgensen is the chief executive of Novo Nordisk who reported on the sales growth of its GLP-1 brands.
6